Furthermore, osteocalcin levels have been found to inversely correlate with key glycemic markers, such as FBS and HbA1c, suggesting that reduced osteocalcin levels may be associated with poor glycemic control in T2DM patients [5]. This evidence concerns the gene BGLAP and type 2 diabetes mellitus.